Levocetirizine Impurity 13 - Request Quote
Levocetirizine Impurity 13
| SZ CAT No: | SZ-L045035 |
| CAS No | NA |
| Mol.F. | C24H26Cl2N2O2S |
| Mol.Wt. | 477.4 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Levocetirizine Impurity 13 is chemically (R)-N-(2-Chloroethyl)-N-(2-(((4-chlorophenyl)(phenyl)methyl)amino)ethyl)-4-methylbenzenesulfonamide. Levocetirizine Impurity 13 is supplied with detailed characterization data compliant with regulatory guideline. Levocetirizine Impurity 13 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Levocetirizine.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
buy high quality Levocetirizine Impurity 13
Purchase Levocetirizine Impurity 13
Levocetirizine Impurity 13 suppliers
Levocetirizine Impurity 13 manufacturers
Levocetirizine Impurity 13 price
Order Levocetirizine Impurity 13
Enquire Levocetirizine Impurity 13
Levocetirizine Impurity 13 cost
Levocetirizine Impurity 13 Supplier
Levocetirizine Impurity 13 Distributor
Levocetirizine Impurity 13 for Method Validation
Levocetirizine Reference Standard
Levocetirizine Impurity 13 for ANDA Filing
Levocetirizine Impurity 13 for Forced Degradation Studies
Levocetirizine Impurity 13 Identification Standards
Levocetirizine Impurity 13 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


